Paloma Partners’s Cytosorbents Corp CTSO Stock Holding History

Paloma Partners’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,556	Closed	-$100K	–	2081
2020 Q4	$100K	Buy	+12,556	New	+$105K	﹤0.01%	1511

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners's CTSO Position: Q1 2021 in Review

Paloma Partners sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 12,556 shares — an estimated $100K sold.

Paloma Partners first reported a position in CTSO in Q4 2020 and held it in 1 quarter. The position peaked at $100K in Q4 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

Paloma Partners reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
Paloma Partners sold 12,556 Cytosorbents Corp shares in Q1 2021, an estimated $100K.
Paloma Partners first reported a position in Cytosorbents Corp in Q4 2020 and held it in 1 quarter.
Paloma Partners's Cytosorbents Corp position peaked at $100K in Q4 2020.
96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Paloma Partners's 13F filing for Q1 2021, filed 17 May 2021.